QCast: Data-Driven Dialogue in Drug Development

Quanticate
  • 0.0 (0)
  • Life Sciences

QCast by Quanticate is the podcast for biotech, pharma, and life science leaders looking to deepen their understanding of biometrics and modern drug development. Join co-hosts Tom and Jullia as they explore methodologies, case studies, regulatory shifts, and industry trends shaping the future of clinical research. Where biometric expertise meets data-driven dialogue, QCast delivers practical insights and thought leadership to inform your next breakthrough.

  1. Episode 48: Efficacy Endpoints in Oncology Clinical Trials

    2d ago

    Episode 48: Efficacy Endpoints in Oncology Clinical Trials

    In this QCast episode, Jullia and Tom discuss efficacy endpoints in oncology clinical trials and why endpoint choice shapes how treatment benefit is assessed. They look at overall survival, progression-free survival, objective response rate, disease-free survival, event-free survival, symptom endpoints, and quality-of-life measures. Key Takeaways Overall survival remains one of the clearest measures of patient benefit, but it can require longer, larger trials and may be affected by treatments given after the study therapy.Progression-free survival and objective response rate can show treatment activity earlier, but they answer different questions from overall survival.Scan timing, missed assessments, censoring decisions, symptom questionnaires, and quality-of-life completion rates can all affect endpoint interpretation. ๐Ÿ”— Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. ๐Ÿ“ Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. ๐Ÿ”” Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

    10 min
  2. Episode 47: The Creation of ADaM Datasets for PK Analysis

    May 22

    Episode 47: The Creation of ADaM Datasets for PK Analysis

    In this QCast episode, Jullia and Tom discuss how ADaM datasets are created for pharmacokinetic, or PK, analysis. They look at the role of ADPC for concentration data and ADPP for derived PK parameters, including how these datasets relate to SDTM PC and PP. The episode also covers why timing, dosing information, analysis values, flags and study-specific rules matter when preparing PK data for reporting and review. Key Takeaways ADPC supports PK concentration data, while ADPP supports derived PK parameters such as Cmax, Tmax, AUC and half-life. Both datasets help turn PK data into an analysis-ready structure.PK results depend on the relationship between dosing and sample collection. Planned and actual time points, relative time variables and pre-dose samples all need careful handling.Analysis values, flags and criteria variables help show which records were analysed, which were excluded and why. This makes PK outputs easier to review and reproduce. ๐Ÿ”— Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. ๐Ÿ“ Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. ๐Ÿ”” Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

    9 min
  3. Episode 46: What is Clinical Data Review?

    May 15

    Episode 46: What is Clinical Data Review?

    In this QCast episode, Jullia and Tom discuss clinical data review as an active part of study oversight, rather than a late-stage clean-up exercise. They explore how timely, connected review supports subject safety, data quality, medical review and confident decision-making, especially as trial data now comes from EDC, ePRO, eCOA, labs, imaging, biomarkers, wearables and other sources. Key Takeaways Good review helps teams spot patterns, missing context and signals that may affect trial conduct or subject safety before issues become embedded.A lab result, adverse event or dosing change becomes more useful when it can be reviewed alongside related data at the right point in the study.Dashboards, alerts and automation can help focus attention, but teams still need clear ownership, escalation routes, traceability and risk-based priorities. ๐Ÿ”— Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. ๐Ÿ“ Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. ๐Ÿ”” Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

    12 min
  4. Episode 45: Clinical Trial Management Systems (CTMS)

    May 8

    Episode 45: Clinical Trial Management Systems (CTMS)

    In this QCast episode, Jullia and Tom discuss clinical trial management systems and their role in keeping clinical studies under control. They explain how CTMS differs from EDC, why operational visibility matters across recruitment, monitoring, site activity and documentation, and how a well-used system can support risk-based oversight, audit trails and better decision-making across sponsors, CROs and sites. Key Takeaways A CTMS gives study teams a central view of milestones, site activation, monitoring activity, recruitment, documents, payments and follow-up actions.When CTMS connects with systems such as EDC, eTMF, safety platforms and finance tools, teams can reduce duplicate entry and work from a more reliable operational picture.The right CTMS should reflect real trial workflows, support current guidance expectations around oversight, and help teams act earlier when risks or delays appear. ๐Ÿ”— Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. ๐Ÿ“ Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. ๐Ÿ”” Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

    11 min
  5. Episode 44: Clinical Trial Simulation

    May 1

    Episode 44: Clinical Trial Simulation

    In this QCast episode, co-hosts Jullia and Tom explore clinical trial simulation and how it supports better study design decisions before a trial begins. They explain how simulation uses statistical and mathematical models to test plausible study scenarios, rather than relying on a single fixed assumption. Key Takeaways Simulation helps teams see how a study design may behave under different assumptions around treatment effect, variability, dropout, recruitment, or safety.The right model depends on the question, whether that is dose selection, endpoint choice, interim planning, or operational feasibility.Simulation is most useful when scenarios reflect clinical and operational reality, with clear assumptions, verification, and communication. ๐Ÿ”— Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. ๐Ÿ“ Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. ๐Ÿ”” Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

    13 min
  6. Episode 43: Clinical Study Start Up

    Apr 24

    Episode 43: Clinical Study Start Up

    In this QCast episode, co-hosts Jullia and Tom explore clinical study start up and why it has such a direct effect on how a trial runs once sites begin opening. They look at what study start up actually includes, from feasibility and budgeting to contracts, ethics, and regulatory submissions, and explain why early choices in this phase can shape timelines, site activation, and the amount of operational disruption carried into enrolment. Key Takeaways Feasibility should test whether the study can really run as planned. That means looking beyond protocol intent to site capacity, patient availability, staffing, and day-to-day operational burden.Delays in study start up do not come only from ethics or regulatory review. Budget development, contract negotiation, handoffs, and unclear ownership can quietly add significant waiting time.Start up becomes more predictable when teams treat it as a controlled process. Clear accountability, parallel work where appropriate, and measurement of cycle time and delays all help reduce avoidable slowdowns. ๐Ÿ”— Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. ๐Ÿ“ Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. ๐Ÿ”” Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

    10 min
  7. Episode 42: Medical Device Clinical Trials

    Apr 17

    Episode 42: Medical Device Clinical Trials

    In this QCast episode, Jullia and Tom explore medical device clinical trials and why they differ in important ways from drug studies. They explain what these trials are designed to show, how safety, performance, and clinical benefit are assessed across different types of devices, and why study design depends so heavily on intended use, risk profile, usability, and real-world clinical context. Key Takeaways Understand medical device clinical trials as evidence-generating studies built around safety, performance, and clinical benefit in the context the device will actually be used.Plan development in stages, because device studies often evolve through feasibility, refinement, and pivotal evidence generation rather than following a standard drug-style pathway.Build strong operational control around training, traceability, and device accountability, because study credibility depends on how consistently the device is used and documented in practice. ๐Ÿ”— Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. ๐Ÿ“ Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. ๐Ÿ”” Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

    10 min
  8. Episode 41: What Are SAD MAD Studies?

    Apr 10

    Episode 41: What Are SAD MAD Studies?

    In this QCast episode, Jullia and Tom explore SAD and MAD studies and why they play such a central role in early clinical development. They explain what single ascending dose and multiple ascending dose studies are designed to show, how they help teams build an early picture of safety, tolerability, and pharmacokinetics, and why their value depends on clear escalation rules, fast data review, and disciplined study execution. Key Takeaways Understand SAD and MAD studies as core early-phase designs used to assess single-dose and repeat-dose effects in humans.Use these studies to guide early decisions on dose escalation, accumulation, tolerability, and later dose planning.Plan review processes and operational detail carefully, because timing, data flow, and clear decision rules are critical to generating usable results. ๐Ÿ”— Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. ๐Ÿ“ Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. ๐Ÿ”” Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

    8 min
See All (48)

About

QCast by Quanticate is the podcast for biotech, pharma, and life science leaders looking to deepen their understanding of biometrics and modern drug development. Join co-hosts Tom and Jullia as they explore methodologies, case studies, regulatory shifts, and industry trends shaping the future of clinical research. Where biometric expertise meets data-driven dialogue, QCast delivers practical insights and thought leadership to inform your next breakthrough.

Information